Inácio, J.M.; Cristo, F.; Pinheiro, M.; Vasques-Nóvoa, F.; Saraiva, F.; Nunes, M.M.; Rosas, G.; Reis, A.; Coimbra, R.; Oliveira, J.L.;
et al. Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction. Biomedicines 2023, 11, 2131.
https://doi.org/10.3390/biomedicines11082131
AMA Style
Inácio JM, Cristo F, Pinheiro M, Vasques-Nóvoa F, Saraiva F, Nunes MM, Rosas G, Reis A, Coimbra R, Oliveira JL,
et al. Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction. Biomedicines. 2023; 11(8):2131.
https://doi.org/10.3390/biomedicines11082131
Chicago/Turabian Style
Inácio, José M., Fernando Cristo, Miguel Pinheiro, Francisco Vasques-Nóvoa, Francisca Saraiva, Mafalda M. Nunes, Graça Rosas, Andreia Reis, Rita Coimbra, José Luís Oliveira,
and et al. 2023. "Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction" Biomedicines 11, no. 8: 2131.
https://doi.org/10.3390/biomedicines11082131
APA Style
Inácio, J. M., Cristo, F., Pinheiro, M., Vasques-Nóvoa, F., Saraiva, F., Nunes, M. M., Rosas, G., Reis, A., Coimbra, R., Oliveira, J. L., Moura, G., Leite-Moreira, A., & Belo, J. A.
(2023). Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction. Biomedicines, 11(8), 2131.
https://doi.org/10.3390/biomedicines11082131
